Brief: Zentalis Pharmaceuticals Q1 EPS USD -1.07
10/05/2023 13:28
May 10 (Reuters) - Zentalis Pharmaceuticals Q1 operating expenses USD 64.953 million. * Q1 operating income USD -64.953 million * Q1 pretax profit USD -60.844 million * Q1 net income USD -63.262 million * Q1 EPS USD -1.07
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer